Stock listing
NASDAQ:ARAV Aravive Inc Stock
Follow Aravive Inc into a list and get an email when it puts out news.
Last close · NASDAQ:ARAV
$0.04 USD
Close on Jan 26, 2024 · No longer trades
- Lowest – highest close
- $0.04 – $14.81 USDSince Oct 16, 2018 · lowest Jan 26, 2024 · highest Jun 25, 2020
Delisted NASDAQ:ARAV no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ARAV
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Aravive Inc on 6ix
- Decks
- 32 decks · latest Jun 5, 2023
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (June 2023) | Investor deck | 38 slides | Jun 5, 2023 |
| Investor Presentation (May 2023) | Investor deck | 35 slides | May 16, 2023 |
| Investor Presentation (November 2022) | Investor deck | 38 slides | Nov 29, 2022 |
| Investor Presentation (September 2022) | Investor deck | 39 slides | Sep 27, 2022 |
| Investor Presentation (August 2022) | Investor deck | 37 slides | Aug 26, 2022 |
| Investor Presentation (May 2022) | Investor deck | 54 slides | May 11, 2022 |
| Investor Presentation (March 2022) | Investor deck | 48 slides | Mar 3, 2022 |
| Investor Presentation (January 2022) | Investor deck | 46 slides | Jan 4, 2022 |
| Investor Presentation (November 2021) | Investor deck | 46 slides | Nov 12, 2021 |
| Investor Presentation (October 2021) | Investor deck | 37 slides | Oct 28, 2021 |
All 32 decks
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert E. Hoffman Other companies: CytoDyn Inc. (Chief Financial Officer · Since at least May 15, 2025); Esperion Therapeutics, Inc. (Director · Since at least Apr 1, 2025); FibroBiologics, Inc. (Director · Since at least Jan 24, 2024); TuHURA Biosciences, Inc. (Director · Since at least Apr 11, 2018); Heron Therapeutics, Inc. (CFO & SVP, Finance · Apr 24, 2017 – Dec 19, 2019 · Past); Kura Oncology, Inc. (Director · May 12, 2016 – Jun 22, 2021 · Past); CombiMatrix Corp (Director · May 10, 2016 – Nov 14, 2017 · Past); MabVax Therapeutics Holdings Inc (Director · Aug 26, 2015 – May 19, 2017 · Past) | Director · Oct 12, 2018 – Sep 12, 2019 · Past |
| John Hohneker Other companies: ArriVent BioPharma, Inc. (Director · Since at least May 16, 2024); Curis, Inc. (Director · Since at least Dec 2, 2021); Carisma Therapeutics, Inc. (Director · Apr 1, 2024 – Jun 26, 2024 · Past); Humanigen Inc (Director · Oct 19, 2021 – Jul 27, 2022 · Past); Evelo Biosciences, Inc. (Director · Jan 27, 2021 – Jun 8, 2023 · Past); Dimension Therapeutics (Director · Jan 18, 2017 – Nov 7, 2017 · Past) | Director · May 12, 2021 – Sep 23, 2022 · Past |
| Jay P. Shepard Other companies: Ironwood Pharmaceuticals, Inc. (Director · Since at least Dec 3, 2020); Inovio Pharmaceuticals, Inc. (Director · Since at least Jan 15, 2020); Esperion Therapeutics, Inc. (Director · Since at least May 24, 2018); Marinus Pharmaceuticals Inc (Director · Jul 31, 2014 – Jan 17, 2017 · Past); Durect Corporation (Director · Sep 26, 2013 – Jun 22, 2016 · Past) | Director · Mar 20, 2014 – Jan 9, 2020 · Past |
| R. Scott Greer Other companies: Nektar Therapeutics (Managing Director, Numenor Ventures, LLC · Since at least Sep 15, 2015); Microbot Medical Inc. (Director · Jan 1, 2016 – Jan 1, 2016 · Past); Inogen, Inc (Director · Aug 3, 2015 – May 10, 2021 · Past); Sientra Inc (Director · Jun 26, 2015 – Jun 5, 2018 · Past) | Director · Jun 29, 2015 – Dec 20, 2017 · Past |
| Shahzad Malik Other companies: Acutus Medical Inc. (Director · Aug 5, 2020 – Jun 17, 2021 · Past); Axonics Modulation Technologies Inc (Director · Oct 30, 2018 – Dec 6, 2018 · Past); Histogen Inc (Director · Jun 23, 2016 – Jun 23, 2016 · Past); Agenus Inc. (Director · Jun 15, 2016 – Jun 15, 2016 · Past) | Director · Jun 29, 2015 – Sep 12, 2019 · Past |
| Joshua Brumm Other companies: Crescent Biopharma, Inc. (Chief Executive Officer · Since at least Jun 13, 2025); Dyne Therapeutics, Inc. (CEO & President, Director · Sep 16, 2020 – Mar 8, 2024 · Past); Kaleido Biosciences, Inc. (See Remarks · Feb 27, 2019 – Mar 4, 2019 · Past) | COO and CFO · Nov 12, 2015 – Oct 19, 2017 · Past |
| Tracy M Woody Other companies: Esperion Therapeutics, Inc. (Director · Since at least May 29, 2019); Zevra Therapeutics, Inc. (Chief Commercial Officer · Apr 15, 2015 – Feb 11, 2016 · Past) | Chief Commercial Officer · Mar 22, 2017 – Mar 23, 2018 · Past |
| Jay S. Stout Other companies: Immunovant, Inc. (Chief Technology Officer · Since at least Apr 17, 2023) | SVP, Technical Operations · Oct 6, 2017 – Apr 24, 2018 · Past |
| Colin Hislop | Chief Medical Officer · Oct 19, 2017 – Oct 19, 2017 · Past |
| Edmon R Jennings | Director · Jun 29, 2015 – Dec 20, 2017 · Past |
All 13 people
| Person | Seat |
|---|---|
| Eric Zhang | Director · Oct 12, 2018 – Oct 24, 2022 · Past |
| Leonard Scott Dove | Chief Operating Officer · Mar 21, 2022 – Feb 1, 2023 · Past |
| Maria Carolina Petrini | Chief Commercial Officer · Apr 10, 2023 – Apr 10, 2023 · Past |
Log in to ask 6ix AI your own questions about Aravive Inc.